PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Bisacodyl→

Bisacodyl PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
603-50-9
Molecular formula
C22H19NO4
Molecular weight
361.4 g/mol
Drug class
Stimulant laxativediphenylmethane derivative
Mechanism of action
Converted by intestinal enzymes to an active diphenol metabolite that stimulates colonic mucosa and enteric nerve plexuses, increasing peristalsis and promoting water and electrolyte accumulation in the colon.
Indications / reported uses
  • Short-term treatment of constipation
  • Bowel evacuation before diagnostic or surgical procedures as part of a product-specific bowel-preparation regimen

Sources: US DailyMed — Bisacodyl · NHS — Bisacodyl · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Bisacodyl PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Bisacodyl Permitted Daily Exposure (PDE) report (the Bisacodyl PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Bisacodyl Occupational Exposure Limit (OEL) report (the Bisacodyl OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.